Search - tctmd.com

Displaying 401 - 420 of 1020

Sort: Relevancy | Date

Presentation TVT 2022

Innovation in TMVr: Lessons Learned From the Surgeons

Presenter: Thomas Modine

June 08, 2022

Presentation TVT 2022

First Report of Outcomes of TEER in Patients With Endocardial Leads: Insights From TRILUMINATE and bRIGHT Clinical Trials

Presenter: Georg Nickenig

June 08, 2022

Presentation TVT 2022

Heterotopic Tricuspid Valve Replacement: Considerations for Future Clinical Trials

Presenter: Ori Ben-Yehuda

June 08, 2022

Presentation TVT 2022

Evidence of Structural Valve Deterioration After TAVI: Recent Echo Findings

Presenter: Michael J. Reardon

June 08, 2022

Presentation TVT 2022

Heterotopic Tricuspid Valve Replacement: Future Developments and Novel Applications

Presenter: Brian O'Neill

June 08, 2022

Presentation TVT 2022

Surgical Explants After TAVI Failures: Prohibitive or an Acquired Taste

Presenter: Tsuyoshi Kaneko

June 08, 2022

Presentation TVT 2022

Technical Lessons From TAVI Valve-in-Valve: Contrasting TAV in SAVR and TAV in TAV

Presenter: Janarthanan Sathananthan

June 08, 2022

Presentation TVT 2022

COUNTERPOINT: EU Preferences… Class 1 = ≥ 75 yo

Presenter: Haim Danenberg

June 08, 2022

Presentation TVT 2022

POINT: U.S. Reflections… Class 1 = ≥ 65 yo

Presenter: Philippe Genereux

June 08, 2022

Presentation TVT 2022

From National Registries to Pragmatic Clinical Trials, From Patient-Reported Outcomes to Shared Decision-making: Not One Size Fits All!

Presenter: Sreekanth Vemulapalli

June 08, 2022

Presentation TVT 2022

EFFICACY AND SAFETY OUTCOMES OF CEREBRAL EMBOLIC PROTECTION DEVICES DURING TRANSCATHETER AORTIC VALVE REPLACEMENT: AN UPDATED META-ANALYSIS

Presenter: Arpanjeet Kaur

June 08, 2022

Presentation TVT 2022

Pattern of Hospital-Level Use of Cerebral Embolic Protection for Transcatheter Aortic Valve Replacement and Association with Outcomes

Presenter: AAMER UBAID

June 08, 2022

Presentation TVT 2022

The TRICUS Study EURO: Clinical Results (TricValve)

Presenter: Rodrigo Estevez-Loureiro

June 08, 2022

Presentation TVT 2022

Transcatheter versus surgical aortic valve replacement for severe aortic stenosis: a meta-analysis of randomized clinical trials

Presenter: Yousif Ahmad

June 08, 2022

Presentation TVT 2022

Heterotopic Tricuspid Valve Replacement: Patient Selection and Anatomical Requirements

Presenter: Fabio Brito Jr.

June 08, 2022

Presentation TVT 2022

Keynote Lecture: Unlocking the Mysteries of Tricuspid Valve Disease: Controversies and Technologies1

Presenter: Azeem Latib

June 08, 2022

Presentation TVT 2022

Heterotopic Tricuspid Valve Replacement: From Bench to Bedside

Presenter: Samir Kapadia

June 08, 2022

Presentation TVT 2022

Health-Related Quality of Life after TAVR According to Baseline Flow State and Aortic Valve Gradients

Presenter: Ibrahim Khaleel

June 08, 2022

Presentation TVT 2022

Alternative Transcatheter Solutions

Presenter: Lauren Ranard

June 08, 2022

Presentation TVT 2022

Late Valvuloplasty for Transcatheter Heart Valve Dysfunction

Presenter: Mariama Akodad

June 08, 2022

Advertisement

Innovation in TMVr: Lessons Learned From the Surgeons

First Report of Outcomes of TEER in Patients With Endocardial Leads: Insights From TRILUMINATE and bRIGHT Clinical Trials

Heterotopic Tricuspid Valve Replacement: Considerations for Future Clinical Trials

Evidence of Structural Valve Deterioration After TAVI: Recent Echo Findings

Heterotopic Tricuspid Valve Replacement: Future Developments and Novel Applications

Surgical Explants After TAVI Failures: Prohibitive or an Acquired Taste

Technical Lessons From TAVI Valve-in-Valve: Contrasting TAV in SAVR and TAV in TAV

COUNTERPOINT: EU Preferences… Class 1 = ≥ 75 yo

POINT: U.S. Reflections… Class 1 = ≥ 65 yo

From National Registries to Pragmatic Clinical Trials, From Patient-Reported Outcomes to Shared Decision-making: Not One Size Fits All!

EFFICACY AND SAFETY OUTCOMES OF CEREBRAL EMBOLIC PROTECTION DEVICES DURING TRANSCATHETER AORTIC VALVE REPLACEMENT: AN UPDATED META-ANALYSIS

Pattern of Hospital-Level Use of Cerebral Embolic Protection for Transcatheter Aortic Valve Replacement and Association with Outcomes

The TRICUS Study EURO: Clinical Results (TricValve)

Transcatheter versus surgical aortic valve replacement for severe aortic stenosis: a meta-analysis of randomized clinical trials

Heterotopic Tricuspid Valve Replacement: Patient Selection and Anatomical Requirements

Keynote Lecture: Unlocking the Mysteries of Tricuspid Valve Disease: Controversies and Technologies1

Heterotopic Tricuspid Valve Replacement: From Bench to Bedside

Health-Related Quality of Life after TAVR According to Baseline Flow State and Aortic Valve Gradients

Alternative Transcatheter Solutions

Late Valvuloplasty for Transcatheter Heart Valve Dysfunction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content